MAY 10, 2013: iCo Therapeutics to Raise $3.2 Million

APRIL 24, 2013: Trimel Pharmaceuticals Corporation Completes $40 Million Equity Financing

MARCH 15, 2013: Stem Cell Therapeutics Closes $3.1 Million Financing

MARCH 14, 2013: Ergoresearch Ltd. and Victhom Human Bionics Inc. announce execution of definitive arrangement agreement

DECEMBER 12, 2012: Gilead Sciences to Acquire YM Biosciences

OCTOBER 25, 2012: Warnex to Sell its Bioanalytical Services Division

JULY 18, 2012: Trimel Pharmaceuticals Corporation Completes $7.5 Million Debt Financing

JULY 13, 2012: iCo Therapeutics Closes $2.55 Million Financing

JULY 5, 2012: PharmaGap Receives Independent Value Opinion and Support of Independent Committee for Proposed License to Clinical Value Corporation

JUNE 27, 2012: Sirona Biochem Retains Healthcare Investment Banking Firm Bloom Burton.

JUNE 25, 2012: Bloom Burton & Co. wins 2012 EMDA Award for Healthcare Deal of the Year

JUNE 21, 2012: Bloom Burton & Co. hosts first annual Healthcare Investor Conference.

JUNE 18, 2012: Bloom Burton & Co. Opens the Toronto Stock Exchange

MAY 29, 2012: The Globe and Mail and StarMine Award Bloom Burton & Co.'s Philippa Flint as Canada's Top Earnings Estimator in 2012

MAY 28, 2012: Paladin Labs and Nuvo Research Sign Canadian License Agreement for Synera and a Loan Agreement

MAY 14, 2012: Stellar Pharmaceuticals Inc. Secures US$6.0 Million Term Loan

MAY 2, 2012: Allon Therapeutics announces completion of $10 million private placement

FEBRUARY 29, 2012: YM BioSciences Raises US$80.5 Million from Public Offering

FEBRUARY 8, 2012: Oncolytics Biotech Inc. Closes Bought Deal Financing for Total Gross Proceeds of Cdn$21.3 Million

DECEMBER 5, 2011: Microbix Closes Previously Announced Equity Offering for Gross Proceeds of $448,231

DECEMBER 1, 2011: Stellar to Acquire Tribute Pharmaceuticals to Create Premier North American...

OCTOBER 18, 2011: Allon Therapeutics Completes Equity Offering

OCTOBER 13, 2011: Botaneco to Commence Trading on the TSX Venture Exchange

OCTOBER 7, 2011: Advitech and Natunola Announce Completion of Merger, Private Placement and...

SEPTEMBER 27, 2011: Medicago Completes $25 Million Private Placement

AUGUST 15, 2011: Lorus Therapeutics Completes Unit Offering, Raising Approximately $2.2 Million

JUNE 16, 2011: Innovotech Retains Bloom Burton & Co.

JUNE 14, 2011: Resverlogix Closes Equity Offering

MAY 18, 2011: The Globe and Mail and StarMine Present the Top Analysts of 2011 for Canada

APRIL 5, 2011: Medicago Announces Closing of $17.4 Million Equity Offering

MARCH 22, 2011: Stem Cell Therapeutics Corp. Announces $2 Million Equity Offering

FEBRUARY 3, 2011: Paladin Enters Into Agreement for a $35.0 Million Bought Deal of Common Shares

JANUARY 31, 2011: Miraculins Retains Bloom Burton & Co. for Strategic Advisory Services

JANUARY 20, 2011: VentriPoint Diagnostics Announces Closing of Final Tranche of Unit Private Placement

DECEMBER 23, 2010: YM BioSciences Announces Exercise of Full Over-Allotment Option...

DECEMBER 17, 2010: YM BioSciences Closes Public Offering of Common Shares

DECEMBER 13, 2010: Wellington Financial Provides US$5 Million Growth Capital Commitment to Agility Health

NOVEMBER 8, 2010: Oncolytics Biotech® Inc. Closes Cdn$28.77 Million Bought Deal Financing

SEPTEMBER 16, 2010: Immunovaccine Announces Closing of Its Previously Announced Equity Offering...

AUGUST 19, 2010: Medicago Announces Closing of its Previously Announced Equity Offering...

AUGUST 5, 2010: Miraculins Executes Final Agreement to Acquire PREVU* Skin Cholesterol Test

JUNE 30, 2010: DiaMedica Announces Completion of Sanomune Acquisition and $2.26 Million...

JUNE 16, 2010: Resverlogix Announces CDN $10 Million Equity Offering

JUNE 3, 2010: Resverlogix Confirms CDN $9.2 Million Offering

JUNE 2, 2010: Patient Home Monitoring Announces Completion of Reverse Takeover and Financing

MAY 17, 2010: ConjuChem Announces Proposed Plan of Reorganisation and Compromise

MAY 13, 2010: Medicago Announces Graduation to the TSX and Execution of a $10 Million SEDA

MARCH 11, 2010: ConjuChem Retains Bloom Burton & Co. as Advisor

MARCH 10, 2010: YM BioSciences Closes US$17.5 million Financing

FEBRUARY 1, 2010: YM BioSciences Completes Merger with Cytopia

JANUARY 28, 2010: Resverlogix Announces the Closing of an Additional $8 Million Financing

JANUARY 13, 2010: Medicure Announces Process to Maximize Shareholder Value

DECEMBER 3, 2009: DRM Ventures Inc. Completes Initial Public Offering

DECEMBER 1, 2009: DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition...

NOVEMBER 27, 2009: Medicago Announces Completion of Bought Deal Financing

NOVEMBER 25, 2009: Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement

NOVEMBER 23, 2009: Oncolytics Biotech Inc. Closes US$12.75 Million Unit Offering

NOVEMBER 11, 2009: Chemaphor Inc. Raises Additional Funds in Private Placement

OCTOBER 8, 2009: Med BioGene Closes Final Tranche of Private Placement

SEPTEMBER 1, 2009: Bradmer Announces Completion of Substantial Issuer Bid

AUGUST 5, 2009: Bloom Burton Hires First Healthcare Analyst, Philippa Flint

JUNE 25, 2009: Med BioGene Announces Closing of Second Tranche of Private Placement

JUNE 11, 2009: Paladin Announces Closing of $58.7 Million Bought Deal Financing and Exercise of...

JUNE 5, 2009: Med BioGene Announces Closing of First Tranche of Private Placement

JUNE 5, 2009: Chemaphor Inc. Completes Private Placement

DECEMBER 15, 2008: Dundee Vets Launch Healthcare Boutique